CC1(C)CCc2cc3c(cc2O1)OC(C)(C)C1c2c(ccc4c2CCC(C)(C)O4)OC31
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?